DOCEBO INC (DCBO) Fundamental Analysis & Valuation

NASDAQ:DCBO • CA25609L1058

Current stock price

19.01 USD
-0.66 (-3.36%)
Last:

This DCBO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. DCBO Profitability Analysis

1.1 Basic Checks

  • DCBO had positive earnings in the past year.
  • DCBO had a positive operating cash flow in the past year.
  • Of the past 5 years DCBO 4 years were profitable.
  • DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO Yearly Net Income VS EBIT VS OCF VS FCFDCBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M

1.2 Ratios

  • The Return On Assets of DCBO (18.15%) is better than 94.22% of its industry peers.
  • DCBO's Return On Equity of 50.63% is amongst the best of the industry. DCBO outperforms 96.03% of its industry peers.
  • DCBO's Return On Invested Capital of 28.07% is amongst the best of the industry. DCBO outperforms 96.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DCBO is significantly above the industry average of 10.89%.
  • The last Return On Invested Capital (28.07%) for DCBO is above the 3 year average (16.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROIC 28.07%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
DCBO Yearly ROA, ROE, ROICDCBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200

1.3 Margins

  • DCBO's Profit Margin of 15.46% is amongst the best of the industry. DCBO outperforms 81.59% of its industry peers.
  • DCBO's Profit Margin has improved in the last couple of years.
  • DCBO's Operating Margin of 12.13% is fine compared to the rest of the industry. DCBO outperforms 78.34% of its industry peers.
  • DCBO has a Gross Margin of 80.42%. This is amongst the best in the industry. DCBO outperforms 81.95% of its industry peers.
  • In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
DCBO Yearly Profit, Operating, Gross MarginsDCBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. DCBO Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
  • The number of shares outstanding for DCBO has been reduced compared to 1 year ago.
  • DCBO has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, DCBO has a worse debt to assets ratio.
DCBO Yearly Shares OutstandingDCBO Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
DCBO Yearly Total Debt VS Total AssetsDCBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 3.12 indicates that DCBO is not in any danger for bankruptcy at the moment.
  • DCBO has a better Altman-Z score (3.12) than 66.79% of its industry peers.
  • The Debt to FCF ratio of DCBO is 0.09, which is an excellent value as it means it would take DCBO, only 0.09 years of fcf income to pay off all of its debts.
  • DCBO's Debt to FCF ratio of 0.09 is amongst the best of the industry. DCBO outperforms 81.23% of its industry peers.
  • DCBO has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.03, DCBO is in the better half of the industry, outperforming 60.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Altman-Z 3.12
ROIC/WACC2.78
WACC10.11%
DCBO Yearly LT Debt VS Equity VS FCFDCBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • DCBO has a Current Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • DCBO has a worse Current ratio (1.22) than 64.26% of its industry peers.
  • DCBO has a Quick Ratio of 1.22. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.22, DCBO is doing worse than 63.54% of the companies in the same industry.
  • The current and quick ratio evaluation for DCBO is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
DCBO Yearly Current Assets VS Current LiabilitesDCBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. DCBO Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 56.98% over the past year.
  • Measured over the past years, DCBO shows a very strong growth in Earnings Per Share. The EPS has been growing by 88.99% on average per year.
  • The Revenue has grown by 11.87% in the past year. This is quite good.
  • The Revenue has been growing by 30.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.29% on average over the next years. This is a very strong growth
  • DCBO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.95% yearly.
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DCBO Yearly Revenue VS EstimatesDCBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO Yearly EPS VS EstimatesDCBO Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

8

4. DCBO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 14.08, which indicates a correct valuation of DCBO.
  • 80.87% of the companies in the same industry are more expensive than DCBO, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 25.70, DCBO is valued a bit cheaper.
  • DCBO is valuated reasonably with a Price/Forward Earnings ratio of 11.84.
  • Based on the Price/Forward Earnings ratio, DCBO is valued cheaply inside the industry as 81.23% of the companies are valued more expensively.
  • DCBO's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 14.08
Fwd PE 11.84
DCBO Price Earnings VS Forward Price EarningsDCBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DCBO is valued a bit cheaper than 79.78% of the companies in the same industry.
  • DCBO's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. DCBO is cheaper than 72.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.11
EV/EBITDA 15.15
DCBO Per share dataDCBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of DCBO may justify a higher PE ratio.
  • A more expensive valuation may be justified as DCBO's earnings are expected to grow with 20.92% in the coming years.
PEG (NY)0.74
PEG (5Y)N/A
EPS Next 2Y18.91%
EPS Next 3Y20.92%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCBO Dividend Analysis

5.1 Amount

  • DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCBO Fundamentals: All Metrics, Ratios and Statistics

DOCEBO INC

NASDAQ:DCBO (3/13/2026, 8:19:55 PM)

19.01

-0.66 (-3.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-27
Earnings (Next)05-07
Inst Owners32.89%
Inst Owner Change-4.8%
Ins Owners0.4%
Ins Owner ChangeN/A
Market Cap546.73M
Revenue(TTM)242.69M
Net Income(TTM)37.51M
Analysts80
Price Target25.57 (34.51%)
Short Float %3.44%
Short Ratio2.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.78%
Min EPS beat(2)1.01%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)19.42%
Min EPS beat(4)1.01%
Max EPS beat(4)28.07%
EPS beat(8)7
Avg EPS beat(8)27.59%
EPS beat(12)10
Avg EPS beat(12)11.91%
EPS beat(16)13
Avg EPS beat(16)101.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-0.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)2
Avg Revenue beat(12)-0.68%
Revenue beat(16)2
Avg Revenue beat(16)-0.99%
PT rev (1m)-0.7%
PT rev (3m)-6.28%
EPS NQ rev (1m)3.75%
EPS NQ rev (3m)3.75%
EPS NY rev (1m)5.32%
EPS NY rev (3m)5.32%
Revenue NQ rev (1m)2.33%
Revenue NQ rev (3m)2.33%
Revenue NY rev (1m)3.1%
Revenue NY rev (3m)3.1%
Valuation
Industry RankSector Rank
PE 14.08
Fwd PE 11.84
P/S 2.25
P/FCF 20.11
P/OCF 19.41
P/B 7.38
P/tB 9.34
EV/EBITDA 15.15
EPS(TTM)1.35
EY7.1%
EPS(NY)1.61
Fwd EY8.44%
FCF(TTM)0.95
FCFY4.97%
OCF(TTM)0.98
OCFY5.15%
SpS8.44
BVpS2.58
TBVpS2.03
PEG (NY)0.74
PEG (5Y)N/A
Graham Number8.85
Profitability
Industry RankSector Rank
ROA 18.15%
ROE 50.63%
ROCE 35.53%
ROIC 28.07%
ROICexc 263.9%
ROICexgc N/A
OM 12.13%
PM (TTM) 15.46%
GM 80.42%
FCFM 11.2%
ROA(3y)11.32%
ROA(5y)6.27%
ROE(3y)34.17%
ROE(5y)19.81%
ROIC(3y)16.11%
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)20.39%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y46.55%
PM growth 5YN/A
GM growth 3Y0%
GM growth 5Y-0.34%
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.09
Debt/EBITDA 0.06
Cap/Depr 30.79%
Cap/Sales 0.4%
Interest Coverage 250
Cash Conversion 86.37%
Profit Quality 72.49%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 3.12
F-Score6
WACC10.11%
ROIC/WACC2.78
Cap/Depr(3y)29.27%
Cap/Depr(5y)38.17%
Cap/Sales(3y)0.44%
Cap/Sales(5y)0.64%
Profit Quality(3y)239%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.98%
EPS 3Y88.99%
EPS 5YN/A
EPS Q2Q%18.42%
EPS Next Y18.91%
EPS Next 2Y18.91%
EPS Next 3Y20.92%
EPS Next 5Y22.29%
Revenue 1Y (TTM)11.87%
Revenue growth 3Y19.31%
Revenue growth 5Y30.99%
Sales Q2Q%10.51%
Revenue Next Year10.62%
Revenue Next 2Y11.22%
Revenue Next 3Y11.56%
Revenue Next 5Y26.95%
EBIT growth 1Y55.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year118.64%
EBIT Next 3Y44.38%
EBIT Next 5Y27.18%
FCF growth 1Y-2.9%
FCF growth 3Y182.43%
FCF growth 5Y48.94%
OCF growth 1Y-3.68%
OCF growth 3Y130.92%
OCF growth 5Y40.42%

DOCEBO INC / DCBO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DOCEBO INC?

ChartMill assigns a fundamental rating of 8 / 10 to DCBO.


What is the valuation status of DOCEBO INC (DCBO) stock?

ChartMill assigns a valuation rating of 8 / 10 to DOCEBO INC (DCBO). This can be considered as Undervalued.


How profitable is DOCEBO INC (DCBO) stock?

DOCEBO INC (DCBO) has a profitability rating of 8 / 10.


How financially healthy is DOCEBO INC?

The financial health rating of DOCEBO INC (DCBO) is 8 / 10.